BioSpace News Archive

Universal Serum is the flagship product of Laboratoire Synbionyme, a Paris-based beauty care company that has pioneered probiotic skin care.

Three American pharmacologists in 1998 discovered the vital role that nitric oxide plays in human health.

Ubiquigent Limited, a company focused on enabling and supporting ubiquitin system-focused drug discovery, announced today that it had entered into an agreement with Dorian Therapeutics to provide access to one of its novel small molecule libraries specifically designed to target deubiquitylase (DUB) enzymes.

Lannett Company, Inc. announced the appointment of Melissa V. Rewolinski, PhD, to its board of directors, effective July 1, 2019.

InDemand Interpreting, a portfolio company of Health Enterprise Partners, announced its acquisition by Stratus Video, LLC, a portfolio company of Kinderhook, LLC.

Tmunity Therapeutics, Inc. announced that Usman “Oz” Azam, MD, President and Chief Executive Officer, and members of the management team plan to participate at an investor conference in June 2019.

Allergan plc announced that Chief Commercial Officer William Meury will participate in a fireside chat at the Jefferies 2019 Healthcare Conference in New York, NY.

APRINOIA Therapeutics announces that it has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) for the development of alpha-synuclein PET imaging tracers.

Brings depth of experience and contacts to rapidly expanding gap closure firm